UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: July 28, 2014
Commission File Number 333-133347
PEPTIDE TECNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Nevada 98-0479983
------------------------------------- -------------------------
State or other jurisdiction of (I.R.S. Employer
incorporation or organization Identification No.)
601 Union Street, Two Union Square, 42nd Floor, Seattle, Washington 98101
-------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (206) 236-9555
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: [ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Resignation of Officers Effective July 28, 2014, a letter of resignation
tendered by Erik Odeen as Director of the Company and as Secretary/Treasurer and
Chief Financial Officer was accepted.
Appointment of Board Members and Officer
Effective July 28, 2014, Mr. Brian (Baxter) Koehn has been appointed to the
Board of Directors of the Company to serve as Secretary/Treasurer until he
resign or his successors be elected by the shareholders of the Company or
appointed by the Board of Directors. Baxter Koehn was also appointed to serve as
Chief Financial Officer of the Company
Mr. Baxter Koehn, BA, AMA, EA, is a seasoned executive with over 30 years
experience in corporate management, financial leadership, international
manufacturing & distribution operations. He manages a consulting practice which
provides financial management and strategic-planning advisory services to both
individuals and privately-held company clients. Duties with the company have
included international marketing, the buying and selling of businesses and
business interests as well as developing strategies for acquiring financing and
market share.
In consideration for accepting the appointment of Chief Financial Officer for
the Company, five million (5,000,000) fully vested shares of the Company's
restricted common stock shall be issued to Brian Koehn.
Appointment of Board Members
Effective July 28, 2014, Mr. Selwyn Dennis Cox has been appointed to the Board
of Directors of the Company to serve until he resign or his successors be
elected by the shareholders of the Company or appointed by the Board of
Directors.
Mr. Dennis Cox is a retired business consultant who has served in various
management positions. He has over 35 years experience working in various
manufacturing and service oriented companies. Early in his career, Mr. Cox
joined Canadian Forest Products Ltd. (CFP) a large building products company
producing plywood and hard board paneling, in New Westminster, British Columbia.
Mr. Cox has held a wide variety of positions with CFP: including Buyer, Senior
Buyer, Mill Stores and Maintenance Coordinator and Shipper.
Prior to retiring, Mr. Cox was a consultant for Industrial Equipment Company
Ltd. (IECO) located in Delta, British Columbia, a large bearing distributor and
carrying a full range of power transmission, material handling, fluid power and
other related products.
In consideration for accepting the appointment to the Board of Directors for the
Company, two hundred fifty thousand (250,000) fully vested shares of the
Company's restricted common stock shall be issued to Selwyn Dennis Cox.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
PEPTIDE TECHNOLOGIES, INC.
By: /s/ Scott McKinley
Scott McKinley
Chairman of the Board
Date: July 28, 2014
- 3
